18 years and hundreds of millions of dollars later, CVRx heart-failure device OK'd for U.S. market
August 21, 2019 at 15:49 PM EDT
CVRx announced late last week that the FDA had approved the Barostim Neo, CVRx's pacemaker-esque implantable device. It's been available in Europe for years.
